Skip to main content
Earnings Labs
Relmada Therapeutics, Inc. logo

Relmada Therapeutics, Inc. (RLMD) Earnings

NASDAQ·Healthcare·Biotechnology

$5.26

+0.67%

Mkt Cap $545.43M

EPS — Estimate vs Actual

Mkt Cap

$545.43M

P/E

Fwd P/E

P/S

Rev TTM

EPS TTM

-$1.11